[video] How AI Advances the Safety and Efficacy of Skin Actives

Advances in artificial intelligence (AI) are accelerating skin care innovation, transforming how bioactive peptides are discovered and developed. In this video interview, sponsored by MetaNovas Biotech, Lun Yu, Ph.D., CTO and co-founder of the company, briefly describes the process and how it has enabled the development of three novel peptides with precise biological targets for skin and scalp benefits.

MetaNovas’ MetaPep AI Platform  

MetaNovas Biotech's MetaPep AI platform is a deep learning-driven molecular design platform tailored to create bioactive peptides. This technology has enabled the development of innovative peptides that address some of the most pressing skin care challenges, including:  

• MetaTlr: A senomorphic peptide that reduces inflammatory and allergy markers, balances the skin microbiome and helps skin cells resist the negative impact of UV radiation.
• MetaScalp: An anti-dandruff peptide offering a safer alternative to existing drugs. The ingredient reduces inflammation, balances the scalp microbiome and improves moisturization while showing significant results in clinical trials within 28 days.
• MetaCono: A bicyclic anti-aging peptide that acts on muscular signaling. The active is capable of reducing wrinkles within 30 min. Beyond immediate effects, it boosts collagen III production, improves skin elasticity and delivers long-term wrinkle reduction. 

Watch now to learn more — it's free.

You can also visit MetaNovas Biotech during in-cosmetics Global at stand EU2 or check out their presentation, "Unleashing AI to craft the future of cosmetic ingredients," on April 10, 2025, from 14:45-15:15 in Technical Seminar Theatre 2, Hall 13 (Elicium).